Utilization of Leukocyte Esterase in the Diagnosis of Pediatric Joint Infections
NCT ID: NCT02032732
Last Updated: 2018-11-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
9 participants
OBSERVATIONAL
2013-12-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to test the usefulness of a chemical test strip to detect infection in fluid that is removed from a joint (intra-articular aspiration) in pediatric patients. The test strip measures an enzyme called leukocyte esterase, which has been shown to be useful in detecting the presence of infection in fluids from other parts of the body. This study will assess the efficacy of the leukocyte esterase test as a diagnostic tool for evaluating pediatric joint infections. The hypothesis of the study is that a positive leukocyte esterase test identifies a septic joint in pediatric patients undergoing intraoperative joint aspiration.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pro-calcitonin for Early Detection of Septic Arthritis
NCT02085733
Lateral Epicondylitis Iontophoresis Randomized Control Trial (LERCT)
NCT00435318
Ultrasound Method to Measure Fibrosis of the Liver in Children
NCT02086708
Ultrasound Imaging and Quantitative Vibro-Acoustic Assessment of Rickets Under the Age of Ten
NCT06385938
Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections
NCT03846804
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
suspected infection
leukocyte esterase test on fluid removed by intra-articular aspiration for suspected infection
leukocyte esterase test
leukocyte esterase test on fluid removed by intra-articular aspiration
no suspected infection
leukocyte esterase test on fluid removed by intra-articular aspiration for reason other than suspected infection
leukocyte esterase test
leukocyte esterase test on fluid removed by intra-articular aspiration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
leukocyte esterase test
leukocyte esterase test on fluid removed by intra-articular aspiration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Renal failure patients
* Patients younger than 3 months old
* Patients 18 years of age or older
* Volume of aspirate is less than 1.5 mL
3 Months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Tennessee
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julie Zielinski, M.D.
Role: PRINCIPAL_INVESTIGATOR
UTCOM Chattanooga/Erlanger Health System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Orthopaedics, Erlanger Health System
Chattanooga, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-106
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.